Placebo News and Research

RSS

Synthetic molecule appears to reverse Alzheimer's-related neurological damage

Under ordinary circumstances, the protein tau contributes to the normal, healthy functioning of brain neurons. In some people, though, it collects into toxic tangles that damage brain cells.

25 Jan 2017

New treatment for C.diff infections reduces recurrences by 40%, study finds

A new treatment for Clostridium difficile (C.diff) infections reduces recurrent infections by nearly 40%, a large study has found.

25 Jan 2017

Clinical study finds evidence that mindfulness meditation training combats anxiety

Mindfulness meditation is an increasingly popular treatment for anxiety, but testing its effectiveness in a convincing way has been difficult. Now a rigorously designed, NIH-sponsored clinical trial has found objective physiological evidence that mindfulness meditation combats anxiety.

25 Jan 2017

Hormone can boost activity in brain regions linked to sexual arousal and love

The hormone kisspeptin can enhance activity in brain regions associated with sexual arousal and romantic love, according to new research.

24 Jan 2017

FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.

19 Jan 2017

Curcumin not likely to have therapeutic benefit, report reveals

Curcumin, a compound in turmeric, continues to be hailed as a natural treatment for a wide range of health conditions, including cancer and Alzheimer's disease

12 Jan 2017

Stress hormone has major effect on perception and perceptual learning

Stress is part of our everyday lives - while some thrive on it, it makes others sick. But what does stress do to our senses? When we train them, we can sharpen our senses thereby improve our perceptual performance.

11 Jan 2017

Monthly high dose of vitamin D lowers respiratory infections in older adults

In people over the age of 65, acute respiratory infections--such as the common cold, influenza, or pneumonia--can lead to potentially life-threatening complications.

5 Jan 2017

Researchers find promising results for treating depression with video game interface

Researchers have found promising results for treating depression with a video game interface that targets underlying cognitive issues associated with depression rather than just managing the symptoms.

4 Jan 2017

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.

3 Jan 2017

Novel investigational drug may help restore cardiac function after heart failure

Cimaglermin, a new experimental drug, may help restore cardiac function after heart failure, according to a first-in-man study published today in JACC: Basic to Translational Science.

27 Dec 2016

MDA celebrates FDA approval of new spinal muscular atrophy drug

The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.

23 Dec 2016

Shortened antimicrobial treatment inferior to standard regimen for middle ear infections, study finds

A five-day antimicrobial treatment regimen for middle ear infections in young children is inferior to the standard 10-day regimen, according to newly published research in The New England Journal of Medicine.

22 Dec 2016

Researchers find effective cure for social anxiety disorders

Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders.

21 Dec 2016

First large-scale clinical study of long-acting injectable HIV drug begins

The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today.

21 Dec 2016

Antibiotic gel shows promise in preventing onset of Lyme borreliosis following tick bite

An antibiotic gel based on azithromycin, an antibiotic with antibacterial properties, helps to prevent the onset of Lyme borreliosis following a tick bite.

20 Dec 2016

New SWOG review shows vitamin E and selenium do not prevent colorectal adenomas

Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer.

20 Dec 2016

Landmark clinical trial to test third investigational drug for Alzheimer's disease

An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent Alzheimer's disease.

20 Dec 2016

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.

17 Dec 2016

Novel approach shows promise for treating co-occurring PTSD and SUD

N-acetylcysteine, when combined with group cognitive behavioral therapy, reduced symptoms of posttraumatic stress disorder (PTSD), cravings, and depression significantly more than CBT alone in veterans with co-occurring PTSD and substance use disorder, a particularly difficult-to-treat population, according to the findings of a randomized controlled pilot trial conducted by researchers at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center.

17 Dec 2016

Placebo News and Research

Synthetic molecule appears to reverse Alzheimer's-related neurological damage

New treatment for C.diff infections reduces recurrences by 40%, study finds

Clinical study finds evidence that mindfulness meditation training combats anxiety

Hormone can boost activity in brain regions linked to sexual arousal and love

FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

Curcumin not likely to have therapeutic benefit, report reveals

Stress hormone has major effect on perception and perceptual learning

Monthly high dose of vitamin D lowers respiratory infections in older adults

Researchers find promising results for treating depression with video game interface

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Novel investigational drug may help restore cardiac function after heart failure

MDA celebrates FDA approval of new spinal muscular atrophy drug

Shortened antimicrobial treatment inferior to standard regimen for middle ear infections, study finds

Researchers find effective cure for social anxiety disorders

First large-scale clinical study of long-acting injectable HIV drug begins

Antibiotic gel shows promise in preventing onset of Lyme borreliosis following tick bite

New SWOG review shows vitamin E and selenium do not prevent colorectal adenomas

Landmark clinical trial to test third investigational drug for Alzheimer's disease

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Novel approach shows promise for treating co-occurring PTSD and SUD

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News